The Patent Finder

Intas Pharmaceuticals Ltd.

Also on record
Records under this name other than the patents Intas Pharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.

Showing 1 to 5 of 5 · Back to Intas Pharmaceuticals Ltd.

PatentTitleStatus Expires Confidence
US 9,487,496Process for the preparation of cabazitaxel and its intermediates
Lapsed on the fee record
Ended Nov 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2024From the USPTO record
US 10,688,187Liquid pharmaceutical composition of adalimumab
Lapsed on the fee record
Ended Jun 23, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 23, 2024From the USPTO record
US 8,058,076In-vitro method for testing bioequivalence of iron-sucrose formulation
Lapsed on the fee record
Ended Nov 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 15, 2023From the USPTO record
US 6,710,195Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
Term ended
Term ended Nov 26, 2022 · From the USPTO record
Term endedTerm ended Nov 26, 2022From the USPTO record
US 10,016,447Pharmaceutical composition having improved content uniformity
Lapsed on the fee record
Ended Jul 10, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 10, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited